Companies Cryptocurrencies
Endo International PLC
Endo International PLC
Exchange: Nasdaq Global Select
IPO Date: 03/03/2014
CEO: Mr. Blaise Coleman
Drug Manufacturers General Specialty & Generic Healthcare 🔗
  • ENDP
  • 0.4001
  • 94069112
    market cap
  • -0.0325
If you bought

shares of Endo International PLC (ENDP) on
You would have made
Old Price $12 Current Price $12

Endo International Plc operates as a pharmaceutical company. The company is headquartered in Dublin, Dublin and currently employs 2,910 full-time employees. The firm operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. The company has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The firm’s generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.

Address: Minerva House Simmonscourt Road DUBLIN DUBLIN 4

Stay updated.